EPHA2 and neoplasm: CD19-ENG or EphA2-ENG T cells homed to tumor sites (Fig. 7a), and CD19-ENG T cells proliferated immediately in contrast to EphA2-ENG T cells as judged by bioluminescence imagining, indicative of antigen-dependent T-cell expansion (Fig. 7a,b).